Is osteoarthritis a metabolic disease?

Joint Bone Spine

Volumn 80, Issue 6, 2013, Pages 568-573

  Sellam, Jérémie ^a   Berenbaum, Francis ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Diabetes mellitus; Inflammaging; Metabolic syndrome; Obesity; Osteoarthritis

Indexed keywords

ADIPONECTIN; ADVANCED GLYCATION END PRODUCT; COLLAGENASE 3; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PENTOSIDINE; REACTIVE OXYGEN METABOLITE; STROMELYSIN;

ADIPOGENESIS; ADIPOSE TISSUE; AGING; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CELL DIFFERENTIATION; CHOLESTEROL TRANSPORT; CHRONIC INFLAMMATION; CORONARY ARTERY CALCIFICATION; DIET THERAPY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; EXERCISE; GENETIC POLYMORPHISM; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HAND OSTEOARTHRITIS; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IN VITRO STUDY; INFLAMMATION; INSULIN RESISTANCE; KNEE OSTEOARTHRITIS; LIPID STORAGE; MECHANICAL STRESS; MECHANORECEPTOR; METABOLIC DISORDER; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOARTHRITIS; OSTEOBLAST; OSTEOPHYTE; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; RISK FACTOR; SHORT SURVEY; SYNOVIOCYTE; SYNOVIUM; WEIGHT BEARING; WILD TYPE; ADULT; AGED; COMPLICATION; METABOLIC SYNDROME X; MIDDLE AGED;

ADULT; AGED; HUMANS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OSTEOARTHRITIS; RISK FACTORS;

EID: 84888399985     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.09.007     Document Type: Short Survey

References (80)

1. Guillemin F., Rat A.C., Mazieres B., et al. Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey. Osteoarthritis Cartilage 2011, 19:1314-1322.
2. Bijlsma J.W., Berenbaum F., Lafeber F.P. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011, 377:2115-2126.
3. Berenbaum F., Sellam J. Obesity and osteoarthritis: what are the links?. Joint Bone Spine 2008, 75:667-668.
4. Zhuo Q., Yang W., Chen J., et al. Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol 2012, 8:729-737.
5. Felson D.T., Anderson J.J., Naimark A., et al. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med 1988, 109:18-24.
6. Cooper C., Snow S., McAlindon T.E., et al. Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum 2000, 43:995-1000.
7. Cooper C., Inskip H., Croft P., et al. Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol 1998, 147:516-522.
8. Grotle M., Hagen K.B., Natvig B., et al. Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord 2008, 9:132.
9. Lohmander L.S., Gerhardsson de Verdier M., Rollof J., et al. Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Ann Rheumatic Dis 2009, 68:490-496.
10. Chauffier K., Laiguillon M.C., Bougault C., et al. Induction of the chemokine IL-8/Kc by the articular cartilage: possible influence on osteoarthritis. Joint Bone Spine 2012, 79:604-609.
11. Gosset M., Berenbaum F., Levy A., et al. Mechanical stress and prostaglandin E2 synthesis in cartilage. Biorheology 2008, 45:301-320.
12. Gosset M., Berenbaum F., Levy A., et al. Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene. Arthritis Res Ther 2006, 8:R135.
13. Mobasheri A., Carter S.D., Martin-Vasallo P., et al. Integrins and stretch activated ion channels; putative components of functional cell surface mechanoreceptors in articular chondrocytes. Cell Biol Int 2002, 26:1-18.
14. Priam S., Bougault C., Houard X., et al. Identification of soluble 14-3-3 as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis. Arthritis Rheum 2013, 65:1831-1842.
15. Yusuf E., Nelissen R.G., Ioan-Facsinay A., et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis 2010, 69:761-765.
16. Conde J., Scotece M., Lopez V., et al. Adipokines: novel players in rheumatic diseases. Discov Med 2013, 15:73-83.
17. Lago F., Dieguez C., Gomez-Reino J., et al. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 2007, 18:313-325.
18. Tan W., Wang F., Zhang M., et al. High adiponectin and adiponectin receptor 1 expression in synovial fluids and synovial tissues of patients with rheumatoid arthritis. Semin Arthritis Rheum 2009, 38:420-427.
19. Schaffler A., Ehling A., Neumann E., et al. Adipocytokines in synovial fluid. JAMA 2003, 290:1709-1710.
20. Dumond H., Presle N., Terlain B., et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 2003, 48:3118-3129.
21. Gosset M., Berenbaum F., Salvat C., et al. Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis Rheum 2008, 58:1399-1409.
22. Yusuf E., Ioan-Facsinay A., Bijsterbosch J., et al. Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis. Ann Rheum Dis 2011, 70:1282-1284.
23. Distel E., Cadoudal T., Durant S., et al. The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. Arthritis Rheum 2009, 60:3374-3377.
24. Day C. Metabolic syndrome, or What you will: definitions and epidemiology. Diabetes Vasc Dis Res 2007, 4:32-38.
25. Puenpatom R.A., Victor T.W. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med 2009, 121:9-20.
26. Yoshimura N., Muraki S., Oka H., et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage 2012, 20:1217-1226.
27. Sowers M., Karvonen-Gutierrez C.A., Palmieri-Smith R., et al. Knee osteoarthritis in obese women with cardiometabolic clustering. Arthritis Rheum 2009, 61:1328-1336.
28. Dahaghin S., Bierma-Zeinstra S.M., Koes B.W., et al. Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Ann Rheum Dis 2007, 66:916-920.
29. Karvonen-Gutierrez C.A., Sowers M.R., Heeringa S.G. Sex dimorphism in the association of cardiometabolic characteristics and osteophytes-defined radiographic knee osteoarthritis among obese and non-obese adults: NHANES III. Osteoarthritis Cartilage 2012, 20:614-621.
30. Waine H., Nevinny D., Rosenthal J., et al. Association of osteoarthritis and diabetes mellitus. Tufts Folia Med 1961, 7:13-19.
31. Huffman K.M., Kraus W.E. Osteoarthritis and the metabolic syndrome: more evidence that the etiology of OA is different in men and women. Osteoarthritis Cartilage 2012, 20:603-604.
32. Yoshimura N., Muraki S., Oka H., et al. Association of knee osteoarthritis with the accumulation of metabolic risk factors such as overweight, hypertension, dyslipidemia, and impaired glucose tolerance in Japanese men and women: the ROAD study. J Rheumatol 2011, 38:921-930.
33. Schett G., Kleyer A., Perricone C., et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care 2013, 36:403-409.
34. Frey M.I., Barrett-Connor E., Sledge P.A., et al. The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study. J Rheumatol 1996, 23:716-722.
35. Anderson J.J., Felson D.T. Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol 1988, 128:179-189.
36. Engstrom G., Gerhardsson de Verdier M., Rollof J., et al. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthritis Cartilage 2009, 17:168-173.
37. Hart D.J., Doyle D.V., Spector T.D. Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J Rheumatol 1995, 22:1118-1123.
38. Sturmer T., Sun Y., Sauerland S., et al. Serum cholesterol and osteoarthritis. The baseline examination of the Ulm Osteoarthritis Study. J Rheumatol 1998, 25:1827-1832.
39. Al-Arfaj A.S. Radiographic osteoarthritis and serum cholesterol. Saudi Med J 2003, 24:745-747.
40. Davies-Tuck M.L., Hanna F., Davis S.R., et al. Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women - a prospective cohort study. Arthritis Res Ther 2009, 11:R181.
41. Jonsson H., Helgadottir G.P., Aspelund T., et al. Hand osteoarthritis in older women is associated with carotid and coronary atherosclerosis: the AGES Reykjavik study. Ann Rheum Dis 2009, 68:1696-1700.
42. Kornaat P.R., Sharma R., van der Geest R.J., et al. Positive association between increased popliteal artery vessel wall thickness and generalized osteoarthritis: is OA also part of the metabolic syndrome?. Skeletal Radiol 2009, 38:1147-1151.
43. Nuesch E., Dieppe P., Reichenbach S., et al. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ 2011, 342:d1165.
44. Haara M.M., Manninen P., Kroger H., et al. Osteoarthritis of finger joints in Finns aged 30 or over: prevalence, determinants, and association with mortality. Ann Rheum Dis 2003, 62:151-158.
45. Mobasheri A. Glucose: an energy currency and structural precursor in articular cartilage and bone with emerging roles as an extracellular signaling molecule and metabolic regulator. Front Endocrinol 2012, 3:153.
46. Rosa S.C., Goncalves J., Judas F., et al. Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. Arthritis Res Ther 2009, 11:R80.
47. Shikhman A.R., Brinson D.C., Valbracht J., et al. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol 2001, 167:7001-7008.
48. Rosa S.C., Rufino A.T., Judas F.M., et al. Role of glucose as a modulator of anabolic and catabolic gene expression in normal and osteoarthritic human chondrocytes. J Cell Biochem 2011, 112:2813-2824.
49. Atayde S.A., Yoshinari N.H., Nascimento D.P., et al. Experimental diabetes modulates collagen remodelling of joints in rats. Histol Histopathol 2012, 27:1471-1479.
50. Uchida K., Urabe K., Naruse K., et al. Hyperlipidemia and hyperinsulinemia in the spontaneous osteoarthritis mouse model, STR/Ort. Exp Anim 2009, 58:181-187.
51. Gillery P. Oxidative stress and protein glycation in diabetes mellitus. Ann Biol Clin 2006, 64:309-314.
52. Verzijl N., Bank R.A., TeKoppele J.M., et al. AGEing and osteoarthritis: a different perspective. Curr Opin Rheumatol 2003, 15:616-622.
53. Steenvoorden M.M., Huizinga T.W., Verzijl N., et al. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum 2006, 54:253-263.
54. DeGroot J., Verzijl N., Bank R.A., et al. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation. Arthritis Rheum 1999, 42:1003-1009.
55. Verzijl N., DeGroot J., Thorpe S.R., et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 2000, 275:39027-39031.
56. Verzijl N., DeGroot J., Bank R.A., et al. Age-related accumulation of the advanced glycation endproduct pentosidine in human articular cartilage aggrecan: the use of pentosidine levels as a quantitative measure of protein turnover. Matrix Biol 2001, 20:409-417.
57. Verzijl N., DeGroot J., Ben Z.C., et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 2002, 46:114-123.
58. Nah S.S., Choi I.Y., Lee C.K., et al. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes. Rheumatology 2008, 47:425-431.
59. Nah S.S., Choi I.Y., Yoo B., et al. Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-alpha in human osteoarthritic chondrocytes. FEBS Lett 2007, 581:1928-1932.
60. Rasheed Z., Akhtar N., Haqqi T.M. Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-kappaB in human osteoarthritis chondrocytes. Rheumatology 2011, 50:838-851.
61. Oren T.W., Botolin S., Williams A., et al. Arthroplasty in veterans: analysis of cartilage, bone, serum, and synovial fluid reveals differences and similarities in osteoarthritis with and without comorbid diabetes. J Rehab Res Dev 2011, 48:1195-1210.
62. Triantaphyllidou I.E., Kalyvioti E., Karavia E., et al. Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet. Osteoarthritis Cartilage 2013, 21:322-330.
63. Gkretsi V., Simopoulou T., Tsezou A. Lipid metabolism and osteoarthritis: lessons from atherosclerosis. Prog Lipid Res 2011, 50:133-140.
64. Lippiello L., Walsh T., Fienhold M. The association of lipid abnormalities with tissue pathology in human osteoarthritic articular cartilage. Metabolism 1991, 40:571-576.
65. Tsezou A., Iliopoulos D., Malizos K.N., et al. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes. J Orthop Res 2010, 28:1033-1039.
66. Aspden R.M., Scheven B.A., Hutchison J.D. Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet 2001, 357:1118-1120.
67. Shen C.L., Dunn D.M., Henry J.H., et al. Decreased production of inflammatory mediators in human osteoarthritic chondrocytes by conjugated linoleic acids. Lipids 2004, 39:161-166.
68. Akagi M., Kanata S., Mori S., et al. Possible involvement of the oxidized low-density lipoprotein/lectin-like oxidized low-density lipoprotein receptor-1 system in pathogenesis and progression of human osteoarthritis. Osteoarthritis Cartilage 2007, 15:281-290.
69. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 2003, 14:15-19.
70. Conaghan P.G., Vanharanta H., Dieppe P.A. Is progressive osteoarthritis an atheromatous vascular disease?. Ann Rheum Dis 2005, 64:1539-1541.
71. Findlay D.M. Vascular pathology and osteoarthritis. Rheumatology 2007, 46:1763-1768.
72. Imhof H., Sulzbacher I., Grampp S., et al. Subchondral bone and cartilage disease: a rediscovered functional unit. Invest Radiol 2000, 35:581-588.
73. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013, 21:16-21.
74. Sasaki K., Hattori T., Fujisawa T., et al. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J Biochem 1998, 123:431-439.
75. Xia W., Szomor Z., Wang Y., et al. Nitric oxide enhances collagen synthesis in cultured human tendon cells. J Orthop Res 2006, 24:159-172.
76. Franceschi C., Capri M., Monti D., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007, 128:92-105.
77. Forsyth C.B., Cole A., Murphy G., et al. Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli. J Gerontol A Biol Sci Med Sci 2005, 60:1118-1124.
78. Messier S.P., Loeser R.F., Miller G.D., et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis Rheum 2004, 50:1501-1510.
79. Richette P., Poitou C., Garnero P., et al. Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Ann Rheum Dis 2011, 70:139-144.
80. Riddle D.L., Moxley G., Dumenci L. Associations between statin use and changes in pain, function and structural progression: a longitudinal study of persons with knee osteoarthritis. Ann Rheum Dis 2013, 72:196-203.